New therapies could be on the horizon for people living with epilepsy or anxiety, thanks to a breakthrough discovery by University of Nevada-Lasd Vegas (UNLV), Tufts University School of Medicine, and an international team of researchers studying how proteins interact to control the firing of brain cells. The study, published online on August 7, 2018 in Nature Communications, provides new insight into ways to regulate a specialized "compartment" of cells in the brain that controls their signaling. If scientists and doctors can influence that compartment, they can control the firing of brain cells, which may in turn stop or prevent seizures, among other things. UNLV neuroscientist and lead author Dr. Rochelle Hines said controlling patterns of activity are very important to the brain's function. "If we can better understand how the brain patterns activity, we can understand how it might go wrong in a disorder like epilepsy, where brain activity becomes uncontrolled," Dr. Hines said. "And if we can understand what is important for this control, we can come up with better strategies for treating and improving the quality of life for people with epileptic seizures and maybe other types of disorders as well, such as anxiety or sleep disorders." The article is titled “Developmental Seizures and Mortality Result from Reducing GABAA Receptor α2-Subunit Interaction with Collybistin.” The six-year project moved one step closer to answering decades-old questions about brain wave control, by quantitatively defining how two key proteins -- the GABAA receptor 2 subunit and collybistin -- interact. When the interaction was disrupted in rodent models, EEG tests showed brain waves moving out of control, mimicking patterns seen in humans with epilepsy and anxiety.
Login Or Register To Read Full Story